1[1]Brown P. Pathophysiology of Spasticity[J]. J Neurol Neurosurg Psychiatry, 1994,57:773-777. 被引量：1
2[2]Rowland LP. Stroke, spasticity and botulinum toxin[J]. N Eng J Med, 2002,347:382-383. 被引量：1
3[3]Braddom RL. Physical medicine and rehabilitation[M].2ed edition,W.B. Saunders Company, 2000, 592-615. 被引量：1
4[4]Brashear A,McAfee AL,Kuhn ER,et al.Treatment with botulinum toxin type B for upper-limb spasticity [J]. Arch Phys Med Rehabil, 2003, 84:103-107. 被引量：1
5[5]McGuire JR, Harvey RL. The prevention and management of complications after stroke [J]. Phys Med Rehabil Clin N Am,1999, 10:857-874. 被引量：1
6[6]Mayer N. Clinicophysiologic concepts of spasticity and motor dysfunction in adults with an upper motoneuron lesion[J]. Muscle Nerve, 1997, 6(suppl):S1-S13. 被引量：1
7[7]Kramers de Quervian IA, Simon SR, Pease WS, et al. Gait pattern in the early recovery period after stroke[J]. J Bone Joint Surg, 1996,78-A:1506-1514. 被引量：1
8[8]Totta M, Beneck S. Shoulder dysfunction in stroke hemiplegia[J]. Phys Med Rehabil Clin N Am, 1991, 2:627-641. 被引量：1
9[9]Levin MF. Interjoint coordination during pointing movements is disrupted in spastic hemiparesis[J]. Brain, 1996, 119:281-293. 被引量：1
10[10]Scott AB,Rosenbaum AL,Collins CC. Pharmacologic weakening of extra-ocular muscles[J]. Invest Ophthalmol, 1973,12:924-927. 被引量：1
